Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples under long-term storage

被引:35
作者
José, M [1 ]
Gajardo, R [1 ]
Jorquera, JI [1 ]
机构
[1] Inst Grifols SA, Res & Dev Area, Barcelona 08150, Spain
关键词
D O I
10.1016/j.biologicals.2004.10.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The implementation of nucleic acid amplification technology (NAT) for detection of HCV, HIV-1 and HBV has undoubtedly contributed to the viral safety of blood, reducing the window period. One important matter related to the stability of RNA/DNA is the effect of the storage conditions on samples. In a previous work, we studied the stability of HCV RNA in plasma samples after storage at different temperatures. This work is an update on the follow-up of a sample containing 100 IU/ml HCV RNA for 5 years at -20 degreesC, showing no decrease in the initial titre. The nucleic acid stability of other viruses, such as HIV-1 and HBV, has also been studied. At -20 degreesC, samples containing HIV-1 were followed up for approximately 3 years and the results obtained show no decay in HIV-1 RNA detectability. Regardless of the HIV-1 RNA concentration, samples stored at 5 degreesC maintain their titre for at least 14 days. At 25 degreesC, the HIV-1 RNA half-life was determined at nearly 7 days. The HBV DNA, at 5 degreesC and 25 degreesC, is stable for at least 28 days, regardless of the initial titre. (C) 2004 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 28 条
  • [1] A rapid real-time quantitative polymerase chain reaction for hepatitis B virus
    Brechtbuehl, K
    Whalley, SA
    Dusheiko, GM
    Saunders, NA
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2001, 93 (1-2) : 105 - 113
  • [2] Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT
    Bruisten, SM
    Oudshoorn, P
    vanSwieten, P
    BoeserNunnink, B
    vanAarle, P
    Tondreau, SP
    Cuypers, HTM
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1997, 67 (02) : 199 - 207
  • [3] Current and emerging infectious risks of blood transfusions
    Busch, MP
    Kleinman, SH
    Nemo, GJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (08): : 959 - 962
  • [4] Busch MP, 1997, TRANSFUSION, V37, pS443
  • [5] Evaluation of a transcription-mediated ampliftication-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system
    Candotti, D
    Richetin, A
    Cant, B
    Temple, J
    Sims, C
    Reeves, I
    Barbara, JAJ
    Allain, JP
    [J]. TRANSFUSION, 2003, 43 (02) : 215 - 225
  • [6] Cardoso MD, 1998, INFUSIONSTHERAPIE, V25, P116
  • [7] Comparison of three commercial assays for the quantification of plasma HIV-1 RNA from individuals with low viral loads
    Chew, CB
    Zheng, F
    Byth, K
    Van Asten, M
    Workman, C
    Dwyer, DE
    [J]. AIDS, 1999, 13 (14) : 1977 - 1978
  • [8] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [9] *COMM PROPR MED PR, 1998, INTR NUCL AC AMPL TE
  • [10] Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification
    Damen, M
    Sillekens, P
    Sjerps, M
    Melsert, R
    Frantzen, I
    Reesink, HW
    Lelie, PN
    Cuypers, HTM
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1998, 72 (02) : 175 - 184